Flovent and Bronchiectasis - a phase IV clinical study of FDA data
Summary:
Bronchiectasis is reported as a side effect among people who take Flovent (fluticasone propionate), especially for people who are male, 60+ old, also take Singulair, and have Cystic fibrosis.
The phase IV clinical study analyzes which people have Bronchiectasis when taking Flovent. It is created by eHealthMe based on reports of 44,023 people who have side effects when taking Flovent from the FDA, and is updated regularly.
What is Flovent?
Flovent has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 44,817 Flovent users. Check the latest studies of Flovent.
What is Bronchiectasis?
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection) is found to be associated with 787 drugs and 856 conditions by eHealthMe. Check the latest studies of Bronchiectasis.
44,023 people reported to have side effects when taking Flovent.
Among them, 148 people (0.34%) have Bronchiectasis.
Among these 148 people:
What is the gender of people who have Bronchiectasis when taking Flovent? *
What is the age of people who have Bronchiectasis when taking Flovent? *
What are other drugs people take besides Flovent? *
What are other side effects people have besides Bronchiectasis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Flovent and have Bronchiectasis?
- Check whether Bronchiectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Flovent:
- Flovent (44,817 reports)
Bronchiectasis treatments and more:
- Bronchiectasis (12,460 reports)
How severe was Bronchiectasis and when was it recovered:
Expand to all the drugs that have ingredients of fluticasone propionate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Flovent:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Bronchiectasis:
- Bronchiectasis (787 drugs)
Browse all the conditions that are associated with Bronchiectasis:
- Bronchiectasis (856 conditions)
Related publications that referenced our studies
- Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
- Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
- Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
- Lee JK, Lee J, Park SS, Heo EY, Park YS, Lee CH, Lee SM, Yoon HI, Yim JJ, Yoo CG, Chung HS, "Effect of inhalers on the development of haemoptysis in patients with non-cystic fibrosis bronchiectasis", The International Journal of Tuberculosis and Lung Disease, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Flovent) and Flovent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ibrance cause Thrombocytopenia Aggravated? - 7 seconds ago
- Could Lasix cause Retinitis? - 38 seconds ago
- Could Oxycodone cause Steatorrhea? - 39 seconds ago
- Drug interactions of Rythmol and Benadryl - 57 seconds ago
- Drug interactions of Clozaril and Albuterol - a minute ago
- Drug interactions of Vitamin D and Paxil - a minute ago
- Hepatocellular Carcinoma and Diarrhea Aggravated - a minute ago
- Seizures and Weakness - a minute ago
- Could Lidocaine Hydrochloride cause Analgesic Therapy? - a minute ago
- Sinus Tachycardia and Chest Pain - a minute ago